Join Cooley for the next installment of Breakthrough Bootcamp, an invite-only event featuring panel discussions with insights and analysis from top business and legal minds in life sciences.
Attendees will gain strategic, business-driven insights for the second half of 2026 and beyond from Cooley’s industry network.
If you are interested in attending, please email lsevents@cooley.com.
Agenda
1:30 – 4:20 pm Breakthrough Bootcamp
4:30 – 6:30 pm Networking reception
Key topics
- State of the Market – Get an overview of the current financial landscape, covering key market trends for biotech companies, presented by PwC.
- M&A Readiness: The Journey to the Boardroom – Building a life sciences company isn’t a straight line to M&A – it’s a set of deliberate decisions made over time. This panel examines how founders approach platform development, partnerships and risk to build long-term strategic readiness and optionality.
- Rowook Park (moderator) – Partner, Cooley
- Karen Basbaum – Chief Business Officer, MBX Biosciences; Former SVP of Business Development, Poseida Therapeutics
- Mark Gergen – Strategic Advisor and Board Member; Former Chairman and CEO, Poseida Therapeutics
- Harry Leonhardt – Former General Counsel, Chief Commercial Officer and Corporate Secretary, Poseida Therapeutics
- Johanna Mylet – Former Chief Financial Officer, Poseida Therapeutics
- Regulatory Landscape: MFN and Pricing Pressure – As the life sciences industry enters a period of heightened regulatory complexity, this panel brings together regulatory practitioners to unpack what lies ahead. Panelists will examine the impact of most-favored nation (MFN) pricing and discuss how companies can proactively navigate and adapt to a shifting regulatory landscape.
- Stephanie Hales – Partner, Cooley
- Vince Sampson – Special Counsel, Cooley
- Frances Stocks Allen – Partner, Cooley
- Jenna Ventorino – Partner, Cooley
- Attracting Capital: How Investors Evaluate Life Sciences Opportunities – Explore how investors evaluate opportunities across the life sciences ecosystem and what differentiates companies that successfully attract capital in today’s market.
- Colleen Badgley (moderator) – Partner, Cooley
- Jeremy Caldwell, PhD – Managing Director, Red Tree Venture Capital
- Jay Lichter, Phd – Managing Partner, Avalon BioVentures
- Leighanne Oh – Vice President, Ascenta Capital
- Andy Schwab – Founder and Managing Partner, 5AM Ventures
Stay for the networking reception
Wind down the day with Cooley at a post-panel happy hour. Connect over golden-hour cocktails with our life sciences team and peers from across the industry.
For more information or to register, please email Cooley’s life sciences events team.
At Cooley, we don’t just advise – we accelerate your achievements. Our collaborative approach draws upon unparalleled experience and our extensive industry network to drive strategic solutions and resolve challenges.
With Cooley as your catalyst, you’re not just part of the life sciences industry – you’re shaping it.
Breakthroughs happen with Cooley.